Page 1674 - Clinical Small Animal Internal Medicine

1612 Index

hypoglycemia 103–111 approach to the dermatologic hypoxemia
VetBooks.ir artifactual hypoglycemia 104–105 autoimmune and immune‐mediated canine chronic bronchitis 308
patient 1387
acute respiratory failure 383–386,
acquired hepatic
dysfunction 107–108
384, 385, 389–390, 390, 397–398
skin disease 1426
clinical signs 104, 109 bacterial pyodermas 1464 feline bronchial asthma 299
congenital hepatic disease hypotension mechanical ventilation 393,
103, 105 critical care setting 349 397–398
critical care setting 350 head trauma 755 pulmonary thromboembolism
diabetes mellitus 99–101 pulmonary thromboembolism 319 313, 319
diagnostic approach to septic shock 421, 426–427 respiratory monitoring in critical
associated disorders 106–107, surgical approaches to thoracic care 375–379
109, 110 disease 326 respiratory pattern‐based approach
etiology/pathophysiology hypotensive resuscitation 361 to dyspnea 293
104–111, 104 hypothalamus 35, 36, 41, 50 surgical approaches to thoracic
forebrain disorders 777 hypothermia 431–433 disease 325–326
glycogen storage disease 105–106 cardiopulmonary hypoxia
heat stroke 436 resuscitation 371 hypothermia 432
history 105 etiology/pathophysiology metabolic diseases 680
hypoadrenocorticism 83, 85, 107 431–432 pulmonary hypertension 225
liver disease 650 head trauma 750, 757 shock 403–404
maintenance of normal glucose prognosis 433 hypoxia inducible factor‐1
concentrations 103–104 respiratory pattern‐based approach (HIF‐1) 1209
microvascular dysplasia 105 to dyspnea 292, 295
neonatal and juvenile surgical approaches to thoracic i
hypoglycemia 106 disease 326, 329 IBD see inflammatory bowel disease
nonislet tumor‐induced treatment 432–433 IBS see irritable bowel syndrome
hypoglycemia 106–107 hypothesis testing ICD see implantable cardioverter
pancreatic endocrine tumors clinical decision making 20–21 defibrillators
1297–1298 infectious disease 835–836 ICF see intracellular fluid
paraneoplastic syndromes 1218 statistical interpretation for ICGN see immune complex‐mediated
persistent hyperinsulinemic practitioners 8–10 glomerulonephritis
hypoglycemic syndrome hypothyroidism ichthyosis 1500–1503
108–109 antimicrobials 1047 diagnosis 1503
portosystemic vascular autoimmune polyglandular etiology/pathophysiology
anomalies 103, 105 syndromes 114–115 1500–1501
renal failure 107 cutaneous manifestations of systemic history and clinical signs
sepsis‐induced hypoglycemia 108 disease 1482–1483 1501–1503, 1501–1502
signalment 105 vestibular disease 792–793 prognosis 1503
treatment and prognosis see also canine hypothyroidism signalment 1501
106–107, 109–110 hypoventilation treatment 1503
virulent babesiosis 108 acute respiratory failure 382–384 ICP see intracranial pressure
xylitol toxicity 109–110 mechanical ventilation 393 icterus 642, 642, 721, 723
hypokalemia see potassium homeostasis respiratory monitoring in critical ICU see intensive care unit
and disorders care 378 idiopathic megaesophagus
hypomagnesemia see magnesium surgical approaches to thoracic 559, 564
homeostasis and disorders disease 325–326 idioventricular rhythm 200, 203
hyponatremia see sodium and water hypovolemic shock IE see infectious endocarditis
homeostasis hypoadrenocorticism 82, 89 I:E see inspiratory:expiratory
hypoparathyroidism 1084 portosystemic shunts and IFA see immunofluorescence
hypophosphatemia see phosphorus microvascular dysplasia 715 assay; immunofluorescent
homeostasis and disorders septic shock 422 antibody
hypophosphatemic rickets 1527 sodium and water IFN see interferons
hypophysectomy 46 homeostasis 1071 IGF see insulin‐like growth factor
hypopigmentation/hypomelanosis trauma and burns 453 IHC see immunohistochemistry